1 who collaborating centre for international drug monitoring dr. mohamed farah the uppsala...

37
1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

Upload: marsha-shaw

Post on 16-Dec-2015

217 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

1

WHO Collaborating Centre for International Drug Monitoring

Dr. Mohamed Farah

the Uppsala Monitoring Centre

Page 2: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

2

WHO Drug Monitoring ProgrammeFounding Members 1968

Australia New ZealandCanada Denmark Germany Ireland Netherlands

United States of AmericaUnited KingdomSweden

WHO Drug MonitoringProgramme

WHO Drug MonitoringProgrammeFounding membersFounding members

1968

Page 3: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

3

WHO Programme for International Drug Monitoring

Page 4: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

4

WHO Collaborating Centrethe Uppsala Monitoring Centre

• established as a foundation 1978

• based on agreement Sweden – WHO

• international administrative board

• WHO Headquarters responsible for policy

Page 5: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

5

Signalling ProcedureWhat should be achieved?

• Signals should not be missed

• Signals should be found early

• ‘False’ signals should be kept to a minimum

Page 6: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

6

Process for joining WHO Programme

1. Ministry of Health (or equivalent) designates National Centre

Ministry of Health

National Centre

the UMC

WHO-HQGeneva

1

2

3

4

52. Ministry of Health sends formal application to WHO-HQ, Geneva

3. National Centre sends sample reports to the UMC

4. UMC notifies WHO-HQ that reports are compatible

5. WHO-HQ advises Ministry of Health of admittance to the Programme

Page 7: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

7

Official member

Morocco (1992)

South Africa (1992)

Tunisia (1993)

Zimbabwe (1998)

Ghana (2001)

Nigeria (2004)

Mozambique (2005)

Associate member

Botswana

Democratic Republic of Congo

EritreaEthiopia

Madagascar

Sierra leone

Uganda

Zambia

Algeria

Egypt (2001)

Tanzania (1993)

Africa -WHO

Page 8: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

8

Nomina si nescis, perit et cognitio rerum. (Carl von Linné, Critica botanica)

If you do not know the names, the knowledge about the things vanishes as well.

Page 9: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

9

Page 10: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

10

Page 11: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

11

Isibhaha

Syn: Warburgia breyeri Pott.; Warburgia ugandensis Sprague; Chibaca salutaris Bertl. f.

Uses: Expectorant, Chest infections, Sinusitis, Malaria, Venereal diseases, Stomach ulcers, Toothache and Dermatological disorders

Chemistry

warburganal muzigadial polygodial mukaadial

Warburgia salutaris (Bertol. f.) Chiov.

Common names: Pepper bark tree, Pepperbasboom (Afr.), Shibaha (Tsonga), Amazwecehlabayo (Zulu), Isibaha (Z, V), Manaka (Venda), Sebaha (Sotho)

Muthiga (Kikuyu), Sogdom (Amharic), Msokonoi (Swahili)

Page 12: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

12

Artemisia annua L. leaf

Page 13: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

13

Artemisia annuua L.The plant can grown in many places but it may notcontain artemisinin. For example: Visitors of the ancientpalaces in the forbidden city in beijing can find niceartemisia annua plants pushing left and right as weeds,but these plants do not contain artemisinin

Page 14: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

14

Artemisia annua L.

but a clone from China could contain up to 1.1 % artemisinin

The average artemisinin concentration in plants of European origin range from 0.03 to 0.22 % (dry leaves weight basis) artemisinin,

Page 15: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

15

Artemisia annua L.

1,8-Cineole: leaf pesticide, insectifuge, herbicideAlpha-Pinene: leaf herbicide, insecticide, pesticide, insectifuge, insectiphile

Artemisic-acid: plant: pesticideArtemisinin: flower leaf antimalarial, pesticide, schizonticide, herbicideBeta-Pinene: plant: herbicide, insectifuge, pesticideBeta-Sitosterol: plant: pesticide, antifeedantBorneol: plant: herbicide, insectifuge, pesticide, insect-repellentCamphene: plant: insectifuge, pesticideCamphor: leaf antifeedant herbicide, insect-repellent, insectifuge, pesticideCaryophyllene-oxide: plant: antifeedant, insecticide, pesticideCuminaldehyde: leaf: larvicide, pesticideDelta-Cadinene: plant: pesticideDeoxyartemisinin: plant: pesticideMenthol: plant: pesticide, termiticideOcimene: plant: insecticideP-Cymene: plant: herbicide, insectifuge, pesticideScopoletin: plant: herbicide, pesticideTerpinen-4-ol: plant: herbicide, insectifuge, pesticide

Page 16: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

16

Artemisia annua L., flower, leaf

ARTEMISININ

Antitumor

Antiviral Calcium-Antagonist

Cytotoxic

Herbicide

Immunomodulator

Neurotoxic

Pesticide

Plasmodicide

Schizonticide

Teratogenic

Antimalarial

Page 17: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

17

Artemisia annua L. leaf

Dihydroartemisinin

Arteether Artesunate Artemether

Artemisinin 青蒿素

Page 18: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

18

Artemisinin Synthesis

Page 19: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

19

butsynthetic compound is unlikely to be economicallycompetitive with the naturally produced compound

Artemisinin can be synthesized,

Page 20: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

20

Case report

WHO Record number:Country: GhanaType of report: Spontaneous report/HospitalAge: 54 Years Sex: FemaleAdverse Reaction(s): Face oedema; Oedema periorbitalOutcome: Not recovered Suspected Drug: ArtesunateDrug administration data: 200 Milligram Oral TotalIndication: MALARIAConcomitant Drug(s): Nifedipine 20 Milligram Oral per DayRechallenge action: RechallengeRechallenge outcome: Reaction recurred

Nifedipine: 17 Face oedema 29 Oedema periorbital

Page 21: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

21

ArtemetherTotal number of reports 44

Agitation 6 Headache 9 Paroniria

Anorexia Hypoplasia cerebellar Stomatitis

Ataxia cerebellar Fra Insomnia Sweating increased 2

Confusion Jaundice Urine abnormal 2

Confusion Fra Nausea 2 Vision abnorma

Dizziness 9 Neurosis Vomiting 2

Eye malformation Zaf

Page 22: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

22

Artesunate Reports 22260

Anxiety 8 Alopecia 8 Agitation 341 Face oedema, Gha Abdominal pain 11

Ataxia 2 Cheilitis 29 Anorexia 513 Fever tha,Vnm Allergic reaction Zaf

Delirium Coughing 2 Asthenia Gha Gingival bleeding 2 Dizziness Gha, 1439 Th

Dyspnoea Nausea 990 Bullous eruption Hallucination 20 Hypoaesthesia Tza

0anaemia Epistaxis 3 Confusion 195 Hyperventilation Oedema periorbital Gha

Insomnia 6 Flatulence Depression 53 Hypotension Gha Paranoid reaction 6

Naevus Haematuria Diarrhoea 207 Palpitation 241 Paroniria 52, Gha 1

Rash 2 Jaundice 61 Headache 1161 Spasm generalized Rash maculo-papular 6

Pallor 85 Melaena Stomatitis 40 Urine abnormal 2 Rash erythematous 24

Purpura Pharyngitis vomiting 720 Urticaria 3, 1 Vnm Sweating increased

Pruritus 47 Tachycardia Anaemiah aemolytic 2 Thrombocytopenia 2

Tinnitus 3 Vision abnormal 168

Page 23: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

23

Artemisinin and derivativesThere is a fear that improper use of artemisinin and its

derivatives will spur the malaria parasite to evolve to

resist treatment with the compounds, something that has

happened to all previous malaria therapies

Spread of chloroquine

resistance of Plasmodium falciparum

Page 24: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

24

Natural Mosquito Repellents

*It is ten times more effective than DEET at repelling mosquitoes

Agastache cana (Hook.) Woot. & Standl.

Azadirachta indica Juss f.

Cymbopogon nardus (L.) Rendle

Melissa officinalis L.

Nepeta cataria L.*

Pelargonium citrosum Vanleenii

Pelargonium graveolens L'Her. ex Ait.

Page 25: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

25

Mosquito’s natural enemy

Mosquitofish

Bat 600/h

Page 26: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

26

If you think you're too small tobe effective, you have never been in

bed with a mosquito!

Page 27: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

27

Thank you for your attention!

Page 28: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

28

Is it acceptable that an African child dies of malaria every 30 seconds when safe and effective treatment is available.

Page 29: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

29

”Pull out, Bettyl Pull out...You’ve hit on artery”

Page 30: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

30

Page 31: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

31

Mystic Herbal balm ?

Mystic Herbal balm ?

Page 32: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

32

Page 33: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

33

Page 34: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

34

Page 35: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

35

Page 36: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

36

Page 37: 1 WHO Collaborating Centre for International Drug Monitoring Dr. Mohamed Farah the Uppsala Monitoring Centre

37